Standard

Optogenetics : Applications in neurobiology. / Mikhailova, Maria; Deal, Alex; Budygin, Evgeny; Gainetdinov, Raul.

In: Biological Communications, Vol. 62, No. 4, 2017, p. 261-271.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Mikhailova, Maria ; Deal, Alex ; Budygin, Evgeny ; Gainetdinov, Raul. / Optogenetics : Applications in neurobiology. In: Biological Communications. 2017 ; Vol. 62, No. 4. pp. 261-271.

BibTeX

@article{15c2f1d92a5b4813a65851188850b049,
title = "Optogenetics: Applications in neurobiology",
abstract = "Commonly used neuromodulation techniques such as electrical stimulation or pharmacologic intervention have some technical limitations that preclude dissecting particular cell- or pathway-specific functions in the brain, which is composed of billions of neurons. An advancement of molecular genetics techniques has provided a novel method in neuroscience called optogenetics. Optogenetics uses a combination of genetic and optical methods that provide a means to, with great temporal precision, experimentally control the activation or suppression of specific neuronal sub-populations in heterogeneous brain regions where multiple neuronal subtypes exist; this approach can be performed even on freely moving animals. Thus, this tool can uniquely assist in establishing causality between the disorder and the underlying pathology. Ongoing exploration of pathological mechanisms in various animal models of neuropsychiatric disorders with precise tools such as optogenetics can provide significant advances in the development of more focused approaches to treatment of these disorders. Here, we selectively highlight the major advancements gained by the use of optogenetic tools to uncover at circuit levels mechanisms relevant to neuropsychiatric disorders.",
keywords = "Addiction, Alzheimer{\textquoteright}s disease, Depression, Neuropsychiatric disorders, Opsin, Optogenetics, Parkinson{\textquoteright}s disease, Schizophrenia, Stress",
author = "Maria Mikhailova and Alex Deal and Evgeny Budygin and Raul Gainetdinov",
note = "Publisher Copyright: {\textcopyright} 2017 Mikhailova.",
year = "2017",
doi = "10.21638/11701/spbu03.2017.405",
language = "English",
volume = "62",
pages = "261--271",
journal = "Biological Communications",
issn = "2542-2154",
publisher = "Издательство Санкт-Петербургского университета",
number = "4",

}

RIS

TY - JOUR

T1 - Optogenetics

T2 - Applications in neurobiology

AU - Mikhailova, Maria

AU - Deal, Alex

AU - Budygin, Evgeny

AU - Gainetdinov, Raul

N1 - Publisher Copyright: © 2017 Mikhailova.

PY - 2017

Y1 - 2017

N2 - Commonly used neuromodulation techniques such as electrical stimulation or pharmacologic intervention have some technical limitations that preclude dissecting particular cell- or pathway-specific functions in the brain, which is composed of billions of neurons. An advancement of molecular genetics techniques has provided a novel method in neuroscience called optogenetics. Optogenetics uses a combination of genetic and optical methods that provide a means to, with great temporal precision, experimentally control the activation or suppression of specific neuronal sub-populations in heterogeneous brain regions where multiple neuronal subtypes exist; this approach can be performed even on freely moving animals. Thus, this tool can uniquely assist in establishing causality between the disorder and the underlying pathology. Ongoing exploration of pathological mechanisms in various animal models of neuropsychiatric disorders with precise tools such as optogenetics can provide significant advances in the development of more focused approaches to treatment of these disorders. Here, we selectively highlight the major advancements gained by the use of optogenetic tools to uncover at circuit levels mechanisms relevant to neuropsychiatric disorders.

AB - Commonly used neuromodulation techniques such as electrical stimulation or pharmacologic intervention have some technical limitations that preclude dissecting particular cell- or pathway-specific functions in the brain, which is composed of billions of neurons. An advancement of molecular genetics techniques has provided a novel method in neuroscience called optogenetics. Optogenetics uses a combination of genetic and optical methods that provide a means to, with great temporal precision, experimentally control the activation or suppression of specific neuronal sub-populations in heterogeneous brain regions where multiple neuronal subtypes exist; this approach can be performed even on freely moving animals. Thus, this tool can uniquely assist in establishing causality between the disorder and the underlying pathology. Ongoing exploration of pathological mechanisms in various animal models of neuropsychiatric disorders with precise tools such as optogenetics can provide significant advances in the development of more focused approaches to treatment of these disorders. Here, we selectively highlight the major advancements gained by the use of optogenetic tools to uncover at circuit levels mechanisms relevant to neuropsychiatric disorders.

KW - Addiction

KW - Alzheimer’s disease

KW - Depression

KW - Neuropsychiatric disorders

KW - Opsin

KW - Optogenetics

KW - Parkinson’s disease

KW - Schizophrenia

KW - Stress

UR - http://www.scopus.com/inward/record.url?scp=85063285815&partnerID=8YFLogxK

U2 - 10.21638/11701/spbu03.2017.405

DO - 10.21638/11701/spbu03.2017.405

M3 - Article

AN - SCOPUS:85063285815

VL - 62

SP - 261

EP - 271

JO - Biological Communications

JF - Biological Communications

SN - 2542-2154

IS - 4

ER -

ID: 87889038